We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$195M
AUM Growth
-$288M
Cap. Flow
-$284M
Cap. Flow %
-145.48%
Top 10 Hldgs %
73.17%
Holding
37
New
9
Increased
2
Reduced
10
Closed
15

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$16.7M
2
ILMN icon
Illumina
ILMN
+$13.1M
3
SLNO
Soleno Therapeutics
SLNO
+$11.4M
4
CI icon
Cigna
CI
+$9.97M
5
GILD icon
Gilead Sciences
GILD
+$9.23M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$39M
2
NTRA icon
Natera
NTRA
+$32.1M
3
ARGX icon
argenx
ARGX
+$25.5M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$24.3M
5
VRNA
Verona Pharma
VRNA
+$21.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
26
Geron
GERN
$1.05B
– –
-2,472,836
Closed -$8.75M
IDXX icon
27
Idexx Laboratories
IDXX
$46.1B
– –
-44,972
Closed -$18.6M
JANX icon
28
Janux Therapeutics
JANX
$976M
– –
-236,407
Closed -$12.7M
JAZZ icon
29
Jazz Pharmaceuticals
JAZZ
$17B
– –
-161,812
Closed -$19.9M
LEGN icon
30
Legend Biotech
LEGN
$3.69B
– –
-388,704
Closed -$12.6M
LIVN icon
31
LivaNova
LIVN
$4.29B
– –
-99,700
Closed -$4.62M
DFTX
32
Definium Therapeutics
DFTX
$5.62B
– –
-820,793
Closed -$5.71M
NTRA icon
33
Natera
NTRA
$39.4B
– –
-202,646
Closed -$32.1M
NVO
34
Novo Nordisk
NVO
$197B
– –
-209,984
Closed -$18.1M
UNH icon
35
UnitedHealth
UNH
$375B
– –
-28,115
Closed -$14.2M
VRNA
36
DELISTED
Verona Pharma
VRNA
– –
-454,201
Closed -$21.1M
ZBH icon
37
Zimmer Biomet
ZBH
$19B
– –
-369,004
Closed -$39M
1
2

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Tri Locum Partners held 37 positions worth $195M, down 60% from $483M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Tri Locum Partners withdrew a net $284M in Q1 2025, closing 15 positions and reducing 10 holdings. Its most notable exit was Zimmer Biomet, an estimated $39M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Tri Locum Partners opened a new position in McKesson worth $18.1M.

  • Tri Locum Partners's largest Q1 2025 buy was McKesson: 26,944 shares worth $18.1M.
  • Tri Locum Partners added most to Cigna in Q1 2025, an estimated $9.97M increase.
  • Tri Locum Partners's biggest Q1 2025 reduction was argenx, cutting an estimated $25.5M.
  • Tri Locum Partners fully exited Zimmer Biomet in Q1 2025, selling an estimated $39M.
  • Tri Locum Partners's ten largest holdings make up 73% of its $195M portfolio in Q1 2025.
  • Tri Locum Partners opened 9 new positions and closed 15 in Q1 2025.
  • Tri Locum Partners's portfolio value fell 60% quarter-over-quarter to $195M.

Based on Tri Locum Partners's 13F filing for Q1 2025, filed 14 May 2025.